High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning

BACKGROUND: Glucocorticosteroids (GC) are long-established, widely used agents for induction of remission in inflammatory bowel disease (IBD). Hyperglycaemia is a known complication of GC treatment with implications for morbidity and mortality. Published data on prevalence and risk factors for GC-in...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonnell, Martin, Harris, Richard J, Borca, Florina, Mills, Tilly, Downey, Louise, Dharmasiri, Suranga, Patel, Mayank, Zare, Benjamin, Stammers, Matt, Smith, Trevor R, Felwick, Richard, Cummings, J R Fraser, Phan, Hang T T, Gwiggner, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668301/
https://www.ncbi.nlm.nih.gov/pubmed/33187976
http://dx.doi.org/10.1136/bmjgast-2020-000532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668301/
https://www.ncbi.nlm.nih.gov/pubmed/33187976
http://dx.doi.org/10.1136/bmjgast-2020-000532

Ejemplares similares